CRISPR-Cas systems have provided revolutionary tools for genome editing. The discovery of Cas proteins with alternative activities has now enabled sensitive and robust tools for detecting nucleic acids. Recent reports harnessing these new CRISPR-Cas technologies display their potential for providing low-cost and practical diagnostic tools for pathogen and disease detection.
CITATION STYLE
Sashital, D. G. (2018, April 24). Pathogen detection in the CRISPR-Cas era. Genome Medicine. BioMed Central Ltd. https://doi.org/10.1186/s13073-018-0543-4
Mendeley helps you to discover research relevant for your work.